On July 5, Director and Party Secretary Li Ziping of the State Nuclear Security Technology Center and his team visited Novel Medical for research and guidance. General Manager Liu Mai and Chief Scientist Liu Yaqiang, along with other key leaders, participated in the meeting.
The meeting focused on the theme of "Finding Treasures in the Small and Beautiful Nuclear Technology Applications." General Manager Liu Mai detailed Novel Medical's overall development and highlighted the company's innovative achievements and applications in nuclear technology.
Director Li Ziping and his team also visited the company's nuclear medical and radiation monitoring laboratories, highly praising Everbright's research and innovation capabilities.
Novel Medical, committed to independent innovation, has successfully developed three main product categories: intelligent nuclear radiation monitoring systems, preclinical animal PET/SPECT/CT, and clinical SPECT(/CT). The company is dedicated to promoting the localization of nuclear technology and supporting the national strategy for self-reliance and control.
Language
